18F-FDG PET/CT 在不明原因发热与不明原因炎症中的中国多中心研究
该研究回顾性纳入12家医院376例不明原因发热(FUO)或不明原因炎症(IUO)患者,评估18F-FDG PET/CT的诊断价值及不同病因类别的影像特征。结果显示感染性疾病占33.0%、风湿性疾病占32.4%、恶性肿瘤占19.1%、杂类原因占6.6%、原因不明占8.8%;恶性肿瘤的FDG摄取在SUVmax和视觉评分上均显著高于其他类别疾病(t值范围4.098至5.612,均P<0.001)。基于临床问卷调查,PET/CT为77.4%的患者提供了额外诊断信息,89.6%的患者从PET/CT检查中获益。
要点
- 在376例FUO/IUO患者中,感染性疾病占33.0%,风湿性疾病占32.4%,恶性肿瘤占19.1%。
- 恶性肿瘤的FDG摄取在SUVmax和视觉评分上均显著高于其他类别疾病(均P<0.001)。
- PET/CT为77.4%的患者提供额外诊断信息,89.6%的患者从中获益。
核心结论
- FDG PET/CT是FUO/IUO临床诊断的有价值工具,对进一步研究PET/CT在非肿瘤性疾病中的用途具有重要意义。
研究设计与样本
- 回顾性研究纳入12家医院376例连续接受FDG-PET/CT的FUO/IUO患者。
- FDG摄取采用SUVmax定量评估和4级视觉评分评估。
- 采用临床医生问卷调查评估PET/CT在FUO/IUO诊断中的意义。
主要发现
- 376例患者中感染性疾病占33.0%,风湿性疾病占32.4%,恶性肿瘤占19.1%,杂类原因占6.6%,原因不明占8.8%。
- 各医院间病因分布存在差异,中国病因构成比随时间发生变化。
- 358例(95.2%)患者PET/CT检查有阳性发现,其中局部高摄取病灶219例,非特异性异常摄取(NAU)187例。
- 恶性肿瘤的FDG摄取在SUVmax和视觉评分上均显著高于其他类别疾病(t值范围4.098至5.612,均P<0.001)。
- 基于临床问卷调查,PET/CT为77.4%的患者提供额外诊断信息,89.6%的患者从PET/CT检查中获益。
关键数值与推荐
- FDG摄取定量评估采用SUVmax,视觉评估采用4级评分法。
- 病因分类包括感染性疾病、风湿性疾病、恶性肿瘤、杂类原因及原因不明。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the clinical value of 18F-FDG-PET/CT for the diagnosis of fever of unknown origin (FUO) and inflammation of unknown origin (IUO) in Chinese population, as well as the characteristics of PET/CT in different category of etiological disease. METHODS: A total of 376 consecutive patients with FUO/IUO who underwent FDG-PET/CT at 12 hospitals were retrospectively studied. FDG uptake was quantitatively and visually evaluated, by using SUVmax and a 4-grade scale respectively. A questionnaire survey to the clinicians was used to evaluate the significance of PET/CT in diagnosing of FUO/IUO. Data analysis included the etiological distribution in the study population, image characteristics in different category of diseases, and clinical significance of PET/CT. RESULTS: In 376 studied patients, the infectious diseases accounted for 33.0% of patients, rheumatologic diseases for 32.4%, malignancies for 19.1%, miscellaneous causes for 6.6%, and cause unknown for 8.8%. However, the etiological distribution among hospitals was varied. In addition, the etiological disease composition ratio has changed over time in China. On PET/CT examinations, 358 (95.2%) of the patients had a positive finding. Within them, local high uptake lesion was found in 219 cases, and nonspecific abnormal uptake (NAU) was found in 187 cases. FDG uptake in malignant diseases was significantly higher than in other category diseases both on SUVmax and visual scores (t-value range from 4.098 to 5.612, all P value < 0.001). Based on a clinical questionnaire survey, PET/CT provided additional diagnostic information for 77.4% of patients, and 89.6% of patients benefited from PET/CT examination. CONCLUSIONS: FDG PET/CT is a valuable tool for clinical diagnosis of FUO/IUO, and it is of great significance in further investigating the usefulness of PET/CT in non-neoplastic diseases.
引用
- Wang Q, Li YM, Li Y, et al. 18F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study. Eur J Nucl Med Mol Imaging. 2018. PMID: 30099578. doi:10.1007/s00259-018-4121-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。